1. Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
   Iva Truxova et al, 2023, Journal for ImmunoTherapy of Cancer CrossRef
2. Fertility potential and safety assessment of residual ovarian cortex in young women diagnosed with epithelial borderline and early-stage malignant ovarian tumors
   L. Cacciottola et al, 2024, Gynecologic Oncology CrossRef
3. Non–adjuvant polichemotherapy for advanced ovarian cancer
   F. T. Nosirova et al, 2022, Health care of Tajikistan CrossRef
4. Consumption of β-glucans to spice up T cell treatment of tumors: a review
   Priscilla de Graaff et al, 2018, Expert Opinion on Biological Therapy CrossRef
5. Spatiotemporal multi-scale modeling of radiopharmaceutical distributions in vascularized solid tumors
   Mohammad Kiani Shahvandi et al, 2022, Scientific Reports CrossRef
6. M2 macrophages and regulatory T cells in lethal prostate cancer
   Ann Erlandsson et al, 2019, The Prostate CrossRef
7. Tumor associated macrophages in the molecular pathogenesis of ovarian cancer
   Yousef Yousefzadeh et al, 2020, International Immunopharmacology CrossRef
8. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer
   Yang Song et al, 2017, Biochemical and Biophysical Research Communications CrossRef
9. Immunotyping in tubo‐ovarian high‐grade serous carcinoma by PD‐L1 and CD8+ T‐lymphocytes predicts disease‐free survival
   Akriti Bansal et al, 2021, APMIS CrossRef
10. The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
    Lin Qin, 2024, Discover Oncology CrossRef
11. Principles of diagnosis of ovarian neoplasms — minimization of errors
    Anna E. Protasova et al, 2019, Journal of obstetrics and women's diseases CrossRef
12. IL-17 and colorectal cancer: From carcinogenesis to treatment
    Sepideh Razi et al, 2019, Cytokine CrossRef
13. A study on the correlation between M2 macrophages and regulatory T cells in the progression of colorectal cancer
    Yanlei Chen et al, 2022, The International Journal of Biological Markers CrossRef
14. Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis‐associated adhesion of ovarian cancer cells
    Felix Neuhaus et al, 2024, Clinical and Translational Medicine CrossRef
15. Febrile Temperature Critically Controls the Differentiation and Pathogenicity of T Helper 17 Cells
    Xiaohu Wang et al, 2020, Immunity CrossRef
16. Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints
    Delphine Hudry et al, 2022, Cancers CrossRef
17. Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy
    Monika Bilska et al, 2020, Journal of Oncology CrossRef
18. Next-generation nanotheranostics targeting cancer stem cells
    Asmaa Reda et al, 2019, Nanomedicine CrossRef